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Abstract 
 
Hormone Replacement Therapy (HRT) is therapy for estrogen deficiency and post 
menopausal syndromes, but high cost and unwell-secured therapy. One of alternative 
therapy is the usage of phytoestrogens. The banana peel contains flavones, flavonol, 
flavanone and polimethoxyflavone which are potential as phytoestrogen. The purpose of 
this study was to examine the estrogenic effect of banana peel extract (BPE) development 
of mammary gland of ovariectomized rats. Estrogenic effects was examined based on in vivo 
and in silico experiment. For in vivo experiment, female Sprague-dawley rats aged 50 days 
were ovariectomized. At 70 days of age, 12 rats were treated with BPE 500 mg/kgBB and 
1000mg/kgBB, 5 rats were treated with estradiol 2μg/day while others served as control 
were treated with CMC-Na 0.5% and sacrificed 2 weeks later. The base line ovariectomized 
rats and base line non-ovariectomized rats were sacrificed at 70 days of age. The in silico 
experiment examined by molecular docking between myricetin and estrogen receptor alpha 
(ER-α). The result of in vivo experiment showed that 1000 mg/kgBW BPE induced c-Myc 
expression and enhance ovariectomized rat mammary gland development significantly. 
Meanwhile, molecular docking showed that there are hydrogen bond interaction between 
bioactive compound in BPE and Estrogen Receptor (ER)-α but less powerfull than estrogen 
and ER-α interaction. In summary, BPE can act as an estrogen agonist, resulting in the 
enhancement of c-Myc expression.  
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INTRODUCTION  
 
Estrogen is one of the important hormones 
in regulating of the menstrual cycle, reproduction, 
modulation of bone density and cholesterol 
transport (Jordan, 2004). Estrogen also stimulates 
proliferation of breast glandular epithelial cells by 
binding with estrogen receptors and inducing of 
estrogen receptors-mediated gene transcription 
(Chen et al., 2000). Therefore, large amounts of 
estrogen deficiency causes decreasing quality of 
women life. 
 Estrogen deficiency may affect breast’s 
health and beauty. It also triggers reproductive 
organs health disorder such as hot flashes 
(Achadiat, 2003). Estrogen deficiency usually can 
be treated by taking estrogen from outside of the 
body that is known as hormone replacement 
therapy (HRT). However, HRT is not only 
expensive but also causing breast and endometrial 
cancer. Therefore, an alternative therapy that is 
relatively safer and cheaper is the use of 
phytoestrogen. 
Phytoestrogen is a bioactive compound that 
has estrogen-like structure and activity (Murkies et 
al., 1998). Phytoestrogen binds to and activates 
estrogen receptors so that it gives estrogenic 
effects. Sultana et al. (2008) proved that the BPE 
contains myricetin which is a flavonoid compound 
suspected as phytoestrogen.  
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Myricetin is able to activate ERα and increase 
expression of c-myc so that it stimulates 
proliferation of breast epithelial cells MCF-7. BPE 
is suspected to affect breast glands development 
through the increasing c-myc level because it 
contains myricetin.  
 Estrogenic effects of phytoestrogen are 
influenced by affinity of phytoestrogen and 
estrogen receptor. The greater their affinity and 
interaction, the greater the expression of c-myc and 
cell proliferation. Computational method using 
molecular docking approach performed as a 
method to determine the strength of interaction 
between myricetin and ERα.  
This study was conducted to obtain 
scientific data about BPE estrogenic effects toward 
ovariectomized rats, that BPE could be used as a 
hormone replacement therapy agent. 
 
METHODS 
 
Banana Peels Extract Preparation 
Ripe bananas were harvested from Beran, 
Sleman. Banana’s peel was collected, dried using 
oven under temperature 40
o
C, then it was made 
into powder using a blender (Maspion) and 
extracted with 70% ethanol (maceration). 
Macerate obtained was concentrated using a rotary 
evaporator to obtain viscous extract. 
Animal Study 
Thirty six Sprague Dawley female rats 40-
50 days age with 86-118 grams of weight were 
obtained from Unit Pengembangan Hewan 
Percobaan (UPHP) UGM. The rats were housed in 
plastic cages in a temperature and humidity-
controlled room (25-32 º C and 98% relative 
humidity) and were given free access to food and 
distilled water.   After a 3-d adaptation period, 40 
mice were either sham-operated (n =6) or OVX (n 
=24). 
 
Treatment Groups  
The rats were randomly divided into five 
groups of 6 each that were ovariectomized at the 
age of 50 days and another group wasn’t.  
Ovariectomy (OVX) is an ovarian cutting process 
so that rats in the estrogen-deficient condition. One 
group of OVX mice received 0.5% CMC-Na for 
two weeks as a solvent control, two group of OVX 
mice received 500mg/kgBW BPE and 1000 
mg/kgBW  daily for 2 weeks for two weeks, some 
OVX mice received 17-β-estradiol 2 μg/day per 
orally. At the end of the experiment, the mice were 
killed with petroleum eter. In each experiment, 
body  weights were measured and mamary were 
isolated for the Haematoxyllin and Eosin (H&E) 
and Immunohistochemistry analysis.  
 
Haematoxyllin and Eosin (H&E) Staining 
The first right thoracic mammary gland 
from each animal was carefully dissected and fixed 
in neutral buffered formalin for routine 
histopathological analysis. Briefly, mammary 
glands were dehydrated through a graded ethanol 
series, embedded in paraffin, and 5-_mthick 
sections cut and stained with hematoxylin and 
eosin. Each slide was scored on a 4-point scale 
ranging from 0 (normal) to 4 (severe changes) by a 
pathologist blinded to treatment groups. 
Histopathological changes were further scored 
according to distribution of changes (0.25 focal), 
0.5 (locally diffuse), and 0.75 (diffuse). Therefore, 
the most severely affected sections with severe 
diffuse pathological changes would be scored a 
maximum of 4.75. 
 
Immunohistochemistry 
Sections of 3 mm were obtained from each 
paraffin block of the organs. The section were 
washed and adhered for to poly-L-lysine-coated
 
slides, incubated in prediluted blocking serum at 
25
0
 C, 10 minutes. The slides were stained for 1 
hour at room temperature
 
with primary Ab c-Myc 
(Santa Cruz). After
 
washing with phosphate 
buffered saline (PBS), 100 µl of biotinylated 
universal secondary antibody (Novocastra) were 
applied for 10 minutes at 25° C. The slide was 
incubated with streptavidin-biotin-complex for 10 
minutes, 1 : 2 in PBS and 5% Ab serum was added 
and washed with PBS. Slides were incubated in 
3,3 diaminobenzidin (DAB) solution for 3-8 
minutes and washed with aquadest. The slides 
were counterstained with Hematoxyllin and Eosin, 
4 minutes. Protein expression was assessed under 
light microscope. Positive expression of c-Myc 
will give a dark brown color in the nucleus area.  
 
Molecular Docking  
This method was done using licensed 
software named 2008.10 (Chemical Computing 
Group Inc.). The myricetin structure was built with 
molecule builder and ran energy minimalizing 
using AM1 method. Energy minimalizing step was 
run to get the most stable molecule by finding the 
conformation with lowest energy. Erα 3-D 
structure was taken from protein data bank 
(www.rcsb.org). the docking molecular was run 
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between receptor active site and ligand 
(myricetin). The output of this method is to get 
ligand-receptor interaction with lowest score 
which has highest stability and identified ligand-
receptor interaction type.  
Data Analysis.  
Cell morphology staining with (H&E) and 
c-Myc expression were analyzed by Excell MS 
Office 2003 and semi-log analysis (SPSS 11.5). 
One way Anova was used to assess concentration 
(p<0.05) then post-hoc comparissons were made 
using Tuckey’s significant different test. Molecular 
docking was done to know myricetin-ER α 
interaction. Myricetin-ER α interaction is getting 
stonger when the score is getting down. 
 
RESULTS 
Effect of Banana Peels Extract in 
Ovariectomized Mice Mamary Gland 
Quantitative HE analysis, carried out in a 
wide series of rat mamary glands showed that 
ovariectomized made any differences on mice 
mamary gland lobulus (Fig.1b). Mamary gland 
growth was greater in mice treated BPE 1000 
mg/kgBW (Fig.1f) and treated estradiol (Fig.1d) 
when compared with that of ovariectomized 
control. BPE-treated (Fig.1e) and CMC-Na treated 
(Fig.1c) animals were not significantly different 
from each other. However, size of lobulus cell on 
mice treated BPE 1000 mg/kgBW and estradiol are 
relatively bigger than lobulus on non-
ovariectomized mice.   
Statistically (p>0.05), ovariectomized on 
ovariectomy mice decreased the amount of lobulus 
even it was not significant toward non-
ovariectomy mice groups (Fig.2). Estradiol 
significantly increased the amount of cell lobulus. 
On BPE 500 mg/kgBW treated groups, increased 
lobulus cell unsignificant towards CMC-Na treated 
groups. BPE 1000 mg/kgBW enhanced lobulus 
cell proliferation significantly towards 
ovariectomized control (Fig.2). No significant 
differences between the amount of lobulus cell 
among mice treated BPE 500 mb/kgBW, BPE 
1000 mg/kgBW and estradiol itself.   
Immunohistochemistry 
Expression of c-Myc on mamary gland was 
determined by immunohistochemstry assay. The 
cell which express c-Myc will be brown nearby 
nucleus area. The higher the colour intensity, the 
higher the c-Myc expression. The expression of c-
Myc was positively on NOVX groups (Fig.3a), 
estradiol groups (Fig.3d) and BPE 1000 mg/kgBW 
(Fig.3f) due to brown spot with high intensity. c-
Myc appearance on mamary gland indicated cell 
proliferation.  
Quantification of c-Myc expression on 
mamary lobulus cell (Fig.4) showed that lobulus 
cell in OVX groups expressed c-Myc lower than 
NOVX groups hile estradiol group expressed the 
highest c-myc. Statistically, c-Myc expression on 
NOVX and estradiol were unsignificant. Over all, 
Anova and Tuckey test showed unsignificant 
enhancement of c-Myc expression on each groups. 
Probably, the mechanism of mamary gland 
proliferation on BPE treated rats took another 
pathway.     
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Figure 1. Mice Mamary Gland Hystology (H&E stainning). The experiments was done under light 
microscope with 100x magnification. Non-ovariectomized groups (a), Ovariectomized groups 
(b), CMC-Na groups (c), Estradiol groups (d), BPE 500 mg/kgBB groups (e) and BPE 1000 
mg/kgBW groups (f). Sign  shows lobulus cell. 
 
  
 
Figure 2. Quantitative Analysis of Mamary Gland Lobulus Cell (H&E). Statistical analysis was done using 
ANOVA dan uji Tuckey (p<0,05). Amount of lobulus was shown from average ± standard of error 
(SE) of 3 experiment sign (*) showed significant differences. 
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Figure 3. Determined c-Myc expression by immunohistokimia assay. The experiments was done under 
microscope with 100x magnification. Non-ovariectomized groups (a), Ovariectomized 
groups(b), CMC-Na groups (c), Estradiol groups (d), BPE 500 mg/kgBB groups (e) and BPE 
1000 mg/kgBW groups (f). brown spot in cytoplasm and perinuclear show c-Myc expression. 
sign  show lobulus cell which expressed c-Myc. 
 
 
Figure 4. Quantitative Analysis of C-Myc Expression on Mamary Gland Lobulus Cell 
(Immunohistochemistry). Statistical analysis was done using ANOVA dan uji Tuckey (p<0,05). 
Amount of c-Myc expression on lobulus was shown from average ± standard of error (SE) of 3 
experiment  
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Molecular Docking 
The interaction between ER α and myricetin 
(ligand) was predicted using molecular docking 
software. ER α structure was reached from Protein 
Data Bank with code 1A52. The method of 
docking validation use estrogen receptor and 
native ligand as subjects. Native ligand is estrogen 
(Fig.5) with Root Mean Square Deviation (RMSD) 
= 0,329372. RMSD score < 2 show that the 
method run with high validity. This method could 
predicted the position of ligand on receptor active 
site, ligand-receptor binding and the strength of 
ligand-receptor binding. The ligand on this method 
is myricetin (Fig.6) which is the bioactive 
compound on BPE. The active sited receptor 
placed by myricetin and estrogen (Fig.7) showed 
that both compound placed the same site on 
receptor but with different posed. 
. 
    
Figure 5. Structure of estrogen    Figure 6. Structure of myricetin 
The interaction between estrogen and ERα 
(Fig.7a and 8a) is two interaction of hydrogen 
bonding. The hydrogen bond occured between 
oxygen on 17-hydroxy groups with hydrogen on 
hystidin 524 residu (Fig.7a) and between hydrogen 
on 3-hidroxy groups with oxygen carbonil on 353 
glutamic acid residu (Fig.7a).  
Interaction between myricetin and ERα 
(Fig.7b and 8b)  is two interaction of hydrogen 
bonding. The hydrogen bond occured between 
hydrogen on 4-hidroxy groups with oksignen 
carbonil on histidin 353 residu (Fig.7b) and 
between hydrogen on 5-hydroxy groups with 
oxygen carbonyl on 346 leucin residu (Fig. 7b). 
 
.   
(a) (b) 
Figure 7. 3D docking result appearances. Estrogen (a) and myricetin (b) bind in the same 
place on estrogen  receptor alfa with different pose.  
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(a) (b) 
Figure 8. 2D profile of  ligand-amino acid residu on receptor. Hydrogen bond interactions 
between hystidin 524 and glutamic acid 353 group of estrogen (a) whereas 
myricetin (b) make a hydrogen bond interaction between glutamic acid 353 and 
leusin 346.  sign  showed Hydrogen bond between ligand and amino acid 
residu on receptor. 
 
The strength of ligand-receptor bonding was 
shown by docking score using London dG Scoring 
so that ligand bond with certain poses could be 
estimated. The lower the score, the more optimal 
ligand pose so that the bonding was getting 
stronger and stable. The molecular docking result 
showed that estrogen- ERα interaction gives lower 
score than myricetin- ERα interaction (Table 1). It 
showed that myricetin- ERα  interaction is less 
powerfull than estrogen- ERα interaction. 
 
Table 1. Molecular docking score of Estrogen Receptor (Erα). 
Ligand Score (kkal/mol) 
Estrogen -25,1793 
Myricetin -15,5834 
 
 
 
DISCUSSION 
 
Estrogenic effect as in vivo could be 
examined from the amount of mamary lobulus 
cell and c-Myc expression upregulation. 
Estradiol enhance the amount of mamary 
lobullus cell significantly. BPE 500 mg/kgBW 
treated groups, mammary lobulus cell increased 
unsignificantly towards CMC-Na treated groups. 
BPE 1000 mg/kgBW enhanced lobulus cell 
proliferation significantly towards 
ovariectomized control. Expresssion of c-Myc 
was high on NOVX, estradiol, and BPE 1000 
mg/kgBW groups. 
In silico experiments with molecular 
docking showed model interaction between 
estrogen receptor with the ligand. The result 
showed that myricetin could have such an 
interaction with ERα through hydrogen bonding 
and placed the same active site as estrogen. 
However, myricetin-ERα bonding was less 
powerfull than estrogen-ERα. This phenomena 
showed that estradiol group has higher lobulus 
cell amount and c-Myc expression than BPE 
1000 mg/kgBB.  
However, the interaction of agonists and 
antagonists could not be ascertained with this 
computational method and there is the possibility 
of other flavonoids which are more capable to 
produce estrogenic effect, or perhaps other 
flavonoids blocked myricetin affinity to ERα. 
Thus, this needs to be proven by further studies 
with other compounds contained in BPE test and 
molecular docking of all flavonoid compounds in 
BPE.  
Probably, bioactive compound on BPE 
(myricetin) is a phytoestrogen due to interaction 
with estrogen receptor so that induces mamary 
lobulus cell proliferation. According to Sultana et 
al. (2008), one of BPE bioactive compound is 
myricetin. Maggiolini et al. (2005) on their 
research said that myricetin could enhance 
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mamary lobulus cell proliferation. Probably, 
myricetin promotes mamary epithelial growth via 
certain pathway and activates estrogen receptor 
by binding with the receptor. Those activated 
receptor are going to bind with Estrogen 
Response Element (ERE) (Van der Woude et al., 
2005) and induces estrogen responsive gene 
expression, one of them is c-Myc expression. c-
Myc and cyclin D are G1 phase regulatory 
protein so that those could induces phase G1 
cycle cell (Gardner et al., 2003). 
Some protein such as c-Myc and cyclin D 
play a role in transition step between G1 Phase 
and S phase. Those induces cyclin E-Cdk2-p130 
complex formation and cyclin E-Cdk2-p21 
inactive complex deformation  (Doisneau-Sixou 
et al., 2003). Cyclin E-Cdk2 complex that release 
from p21, will bind with p130 that phosporilated 
E2F-pRb inactive complex become free E2F 
stimulating S phase. But, the proposed 
mechanism needs to be explored further to know 
the exact mechanism of BPE. 
Overall, this research showed that BPE 
has an estrogenic effect proved by enhancing 
mamary lobulus cell and c-Myc expression. So 
that, BPE is a potential herbs to be explored 
further as estrogen-deficiency drugs. Probably 
myricetin promotes mamary epithelial growth via 
certain pathway that needs to be explored further.       
 
CONCLUSION 
 
BPE dose 1000 mg/kgBW enhances 
mamary gland development and induces c-Myc 
expression significantly. The molecular docking 
showed the bioactive compound on BPE have a 
good interaction with ERα through hydrogen 
bound and placed the same active site with 
estrogen but estrogen- ERα binding is much 
stronger and stable.  
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